Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2022-05-21 2022-05-20
Drug Identification Number 02507579 02507579
Brand name INCLUNOX HP INCLUNOX HP
Common or Proper name INCLUNOX HP INCLUNOX HP
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ENOXAPARIN SODIUM ENOXAPARIN SODIUM
Strength(s) 150MG 150MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 2LISY 2LISY
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-03-10 2022-03-10
Estimated end date Unknown Unknown
Actual end date 2022-05-20 2022-05-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited inventory has been allocated Limited inventory has been allocated
Health Canada comments